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Abstract
Non-linear mixed-effects models (NLMEMs) are used to improve information gather-
ing from longitudinal studies and applied to treatment evaluation in disease evolution
studies, such as HIV infection. The estimation of parameters and the statistical tests
are critical issues in NLMEMs since the likelihood and the Fisher information ma-
trix have no closed form. An alternative method to numerical integrations, in which
convergence is slow, and to methods based on linearisation, in which asymptotic
convergence has not been proved, is the Stochastic Approximation Expectation-
Maximization (SAEM) algorithm. For the Wald test and the likelihood ratio test,
we propose estimating the Fisher information matrix by stochastic approximation
and the likelihood by importance sampling. We evaluate these SAEM-based tests
in a simulation study in the context of HIV viral load decrease after initiation of an
antiretroviral treatment. The results from this simulation illustrate the theoretical
convergence properties of SAEM. We also propose a method based on the SAEM
algorithm to compute the minimum sample size required to perform a Wald test of
a given power for a covariate effect in NLMEMs. Lastly we illustrate these tests on
the evaluation of the effect of ritonavir on the indinavir pharmacokinetics in HIV
patients and compare the results with those obtained using the adaptative Gaussian
quadrature method implemented in the SAS procedure NLMIXED.
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1 Introduction
Most clinical trials aim at comparing the efficacy of two different treatments or
studying the effect of co-medication or physiological covariates. To assess whether
the effect of such covariates implies a better reduction of the disease than without
the covariates, several biological endpoints are repeatedly measured along the trial
extent. The statistical approaches commonly used to study the influence of the
covariate are classically based on the final measurements of this longitudinal data.
Alternative methods to improve information extraction from longitudinal studies
are analyses based on linear or non-linear mixed-effects models (NLMEMs). Such
models have been developed for disease evolution studies, to determine the efficacy of
anti-viral treatments in human immunodeficiency virus (HIV) [1, 2, 3, 4] or hepatitis
B virus [5] infections evaluated through measures of viral load evolution, or prostate
cancer treatment assessed by prostate-specific antigen dosage [6]. NLMEMs are also
used to model the evolution of functional markers, for instance, for the decay of
functional capacity in patients with rheumatoid arthritis [7], or the evolution of the
ventilation function in patients with asthma [8]. NLMEMs are also powerful tools
to analyze the pharmacokinetic properties of a drug. They allow for decreasing the
number of samples per subject, which is an important advantage for interaction
studies of protease inhibitors in HIV infected patients, for example [9].
Analysis of the covariate effect based on longitudinal data is thus essential. The
properties of the statistical tests used to perform this analysis are based on the
maximum likelihood (ML) theory. However, because of the non-linearity of the
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regression function in the random effects, the likelihood of NLMEMs cannot be ex-
pressed in a closed form and the estimation of parameters by ML theory is complex.
This situation leads to the development of widely used estimation methods based
on likelihood linearization. These algorithms realize a first-order linearization of
the regression function, as in the First Order and First Order Conditional Esti-
mate (FOCE) algorithms [10, 11] implemented in the NONMEM software and in
the nlme function of Splus and R software [12]. However these approximate meth-
ods cannot be considered as fully established theoretically. Furthermore, Vonesh
gives an example of a specific design resulting in inconsistent estimates obtained
with linearization methods, such as when the number of observations per subject
does not increase faster than the number of subjects [13]. Particularly, convergence
assumptions, on which the statistical tests are based, are not fulfilled. For instance,
several authors show an inflation of the type I error by simulation of the most widely
used group comparison tests, the Wald test and the Likelihood Ratio Test (LRT)
[14, 15, 16, 17]. Thus, methods with proven convergence and consistency for finding
the maximum likelihood estimate in NLMEMs are required.
Several estimation methods of conventional ML theory have been proposed as
alternatives to linearization algorithms. A common method to handle numerical
integrations is the adaptative Gaussian quadrature (AGQ) method. Estimation al-
gorithms of parameters in a generalized mixed model and in a NLMEM based on
this classical AGQ method have been proposed by Pinheiro and Bates [18] and are
implemented in the SAS procedures GLIMMIX and NLMIXED, respectively [19].
However, the AGQ method requires a sufficiently large number of quadrature points
implying an often slow convergence, which is not very stable. Improvement upon this
method is thus needed. A second common method to handle numerical integrations
is importance sampling, which is a stochastic integration method. However, as em-
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phasized by Ge el al. [20], to achieve satisfactory numerical stability, this method can
be computationally intensive, and hence numerically less efficient than many other
parametric methods. The tool most commonly used to estimate models with missing
or non-observed data such as random effects is the Expectation-Maximization (EM)
algorithm [21]. The widespread popularity of the EM is largely due to its monotonic-
ity: the likelihood increases at every step. Furthermore, the convergence of the EM
algorithm has been widely studied [21]. Because of the non-linearity of the model,
stochastic versions of the EM algorithm are proposed. Wei et al. [22]; Walker [23]
and Wu [24, 25] propose MCEM algorithms, with a Monte-Carlo approximation of
the expectation of the sufficient statistics in the E-step. This Monte-Carlo imple-
mentation is based on independently distributed samples with the posterior density
of the parameters conditional on the observations. However the MCEM algorithm
may have computational problems, such as slow or even no convergence and the
large sample simulations realised by Monte Carlo Markov Chain (MCMC) proce-
dure at each iteration are time consuming. Furthermore, the replication choice of
the Monte Carlo sample is a central issue to guarantee convergence, and this prob-
lem remains unsolved. As an alternative to address both the pointwise convergence
and the computational problem, we propose stochastic approximation versions of
EM (SAEM) [26, 27]. This algorithm requires the simulation of only one realization
of the missing data at each iteration, which substantially reduces computation time.
In addition, pointwise almost sure convergence of the estimate sequence to a local
maximum of the likelihood has been proved under general conditions [26]. Kuhn
and Lavielle [28] propose to combine the SAEM algorithm with a MCMC procedure
adapted to NLMEMs.
The first objective of this paper is to propose ML statistical tests for NLMEMs
based on this SAEM algorithm. The Wald test statistic requires the computation
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of the standard errors (SEs) of the estimated parameters. The inverse of the Fisher
information matrix provides an upper bound of the estimated variance matrix but
has no closed form because of the incomplete data structure. Therefore, we propose
an estimate of this Fisher information matrix on the basis of Louis’ principle [29]
and the stochastic approximation procedure implemented in SAEM. To estimate the
likelihood required for the LRT, we propose to use an importance sampling proce-
dure. We then implement these methods and evaluate them in a simulation study
of HIV infection dynamics. We simulate datasets from the bi-exponential model for
HIV dynamics proposed by Ding and Wu [14], and evaluate the statistical properties
of the SAEM parameter estimates, the standard error and the likelihood estimates.
We also evaluate the type I error and the power of the tests for a comparison of
a treatment effect on one parameter. Methods for minimum required sample size
determination are needed for group comparison tests based on NLMEMs. Kang et
al. [30] propose a method to compute sample sizes given a test hypothesis, based
on a first-order linearization of the NLMEM. The second objective of this paper is
to propose an alternative to this linearization-based approach, by using a SAEM-
based approach. The sample size computation method is illustrated on the same
HIV dynamics example.
After describing the model and notations (section 2), section 3 describes the
SAEM algorithm and the statistical tests. Section 4 reports the simulation study
and its results. Section 5 illustrates these tests on the evaluation of the effect of
ritonavir on the indinavir pharmacokinetics, in patients with HIV infection. We
compare the results with those obtained using the adaptative Gaussian quadrature
method implemented in the SAS procedure NLMIXED. Section 6 concludes the
article with some discussion.
4
H
AL author m
anuscript    inserm
-00169790, version 1
2 Models and notations
Let us define yi = (yi1, . . . , yini) where yij is the response value for individual i at
time tij, i = 1, . . . , N , j = 1, . . . , ni, and let us define y = (y1, . . . , yN). We define
an NLMEM as follows:
yij = f(φi, tij) + g(φi, tij) εij,
εi ∼ N (0, σ
2Ini), (1)
φi = Xiµ+ bi,with bi ∼ N (0,Ω),
where f(·) and/or g(·) are non-linear functions of φ, εi = (εi1, . . . , εini) represents
the residual error, φi is a p-vector of individual regression parameters, µ is the k×p-
matrix of fixed effects, Xi is the k-vector of known covariates, bi is a p-vector of
random effects independent of εi, σ
2 is the residual variance, Ini the identity matrix
of size ni and Ω quantifies the variance matrix of the random effects. The maximum
likelihood estimation in NLMEM is based on the log-likelihood function L(y ; θ) of
the response y, with θ = (µ,Ω, σ2) ∈ Θ the vector of all the parameters of the model.
This function is equal to:
L(y ; θ) =
N∑
i=1
L(yi ; θ) =
N∑
i=1
log
(∫
p(yi, φi; θ) dφi
)
, (2)
where p(yi, φi; θ ) is the likelihood of the complete data (yi, φi) of the i-th subject
and is equal to p(yi, φi; θ) =
∏ni
j=1 p(yij|φi; θ)p(φi; θ). As the random effects φi are
unobservable and the regression functions are non-linear, the integral (2) has no
closed form.
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3 Estimation algorithm and group comparison tests
3.1 The SAEM algorithm
The EM algorithm is a classical approach to estimate parameters of models with
non-observed or incomplete data [21]. For NLMEMs, the non-observed vector is the
individual parameter vector φ = (φ1, . . . , φN) and the complete data of the model is
(y, φ). Let us define the function Q(θ|θ′) = E(Lc(y, φ; θ)|y; θ
′), where Lc(y, φ; θ) is
the log-likelihood of the complete data. At the m-th iteration of the EM algorithm,
the E step is the evaluation of Qm(θ) = Q(θ | θ̂m), whereas the M step updates θ̂m by
maximizing Qm(θ). For cases in which the E step has no analytic form, Delyon et al.
[26] introduce a stochastic version of the EM algorithm that evaluates the integral
Qm(θ) by a stochastic approximation procedure. The authors prove the convergence
of this SAEM algorithm under general conditions if Lc(y, φ; θ) belongs to a regular
curved exponential family:
Lc(y, φ; θ) = −Λ(θ) + 〈S(y, φ),Φ(θ)〉,
where 〈., .〉 is the scalar product and S(y, φ) is the minimal sufficient statistic of
the model. The E step is then divided into a simulation step (S step) of the non-
observed data φ(m) under the conditional distribution p(φ|y; θ̂m) and a stochastic
approximation step (SA step) of E
(
S(y, φ)|θ̂m
)
:
sm+1 = sm + γm(S(y, φ
(m))− sm), (3)
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using (γm)m≥0 a sequence of positive numbers decreasing to 0. The M step is thus
the update of the estimate θ̂m:
θ̂m+1 = argmax
θ∈Θ
(−Λ(θ) + 〈sm+1,Φ(θ)〉) .
For NLMEMs, the SA step reduces to:
s1,i,m+1 = s1,i,m + γm
(
φ
(m)
i − s1,i,m
)
, i = 1, . . . , N,
s2,m+1 = s2,m + γm
(
N∑
i=1
φ
(m)t
i φ
(m)
i − s2,m
)
,
s3,m+1 = s3,m + γm
∑
i,j
(
yij − f(φ
(m)
i , tij)
g(φ
(m)
i , tij)
)2
− s3,m
 ,
and θ̂m+1 is obtained in the maximization step as follows:
µ̂m+1 =
(
N∑
i=1
X tiXi
)−1 N∑
i=1
X tis1,i,m+1,
Ω̂m+1 =
1
N
(
s2,m+1 −
N∑
i=1
(Xiµ̂m+1)s
t
1,i,m+1 −
N∑
i=1
s1,i,m+1(Xiµ̂m+1)
t +
N∑
i=1
(Xiµ̂m+1)(Xiµ̂m+1)
t
)
,
σ̂2m+1 =
s3,m+1∑N
i=1 ni
.
However, the simulation step can be complex when the posterior distribution
p(φ|y; θ) has no analytical form, such as for NLMEMs. Therefore an MCMC pro-
cedure such as the Metropolis-Hastings algorithm can be used to simulate φ(m). At
the m-th iteration of the SAEM algorithm, the S step is thus the simulation of φ(m)
with use of a Metropolis-Hastings algorithm which constructs a Markov Chain, with
p(φ|y; θ̂m) as the unique stationary distribution (see [27] for more details). Kuhn
and Lavielle [27] present the details of the SAEM implementation and prove that un-
der general hypotheses, the sequence (θ̂m)m≥0 obtained by this algorithm converges
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almost surely towards a (local) maximum of the likelihood L(y; ·).
3.2 Estimation of the Fisher Information matrix with stochas-
tic approximation
The computation of the standard errors (SEs) of the estimated parameters is needed
to perform the Wald test and to compute the required minimum sample size. These
SEs can be evaluated as the diagonal elements of the inverse of the Fisher information
matrix estimate, of which evaluation is complex because it has no analytic form. We
adapt the estimation of the Fisher information matrix, proposed by Delyon et al.
[26] and based on the Louis’ missing information principle [29]. The Hessian of
L(y; θ) can then be expressed as:
∂2θL(y; θ) = E
[
(∂2θLc(y, φ; θ)
)
+Var (∂θLc(y, φ; θ)) .
The Jacobian of L(y; θ) is the conditional expectation of the complete data likeli-
hood:
∂θL(y; θ) = E (∂θLc(y, φ; θ)|y, θ) .
For NLMEMs, the derivatives ∂θLc(y, φ; θ) and ∂
2
θLc(y, φ; θ) have analytical forms.
Therefore we implement their estimation using the stochastic approximation proce-
dure of the SAEM algorithm. At the m-th iteration of the algorithm, we evaluate
the 3 following quantities:
∆m+1 = ∆m + γm
(
∂θLc(y, φ
(m+1); θ̂m+1)−∆m
)
,
Gm+1 = Gm + γm
(
∂2θLc(y, φ
(m+1); θ̂m+1) + ∂θLc(y, φ
(m+1); θ̂m+1)∂θLc(y, φ
(m+1); θ̂m+1)
t −Gm
)
,
Hm+1 = Gm+1 −∆m+1∆
t
m+1.
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As the sequence (θ̂m)m≥0 converges to the maximum of the likelihood, the sequence
(Hm)m≥0 converges to the Fisher information matrix.
3.3 Estimation of the likelihood with importance sampling
The computation of the likelihood is needed to perform the LRT. The likelihood
can be computed by adaptative Gaussian quadrature (AGQ) method. However, the
convergence of the AGQ method can be slow and not very stable, especially when the
number p of random effects is large. Alternative methods are stochastic integrations,
such as Monte Carlo or importance sampling methods. Kuhn and Lavielle [27]
propose a simple Monte-Carlo procedure to estimate L(y; θ), the estimate of the log
likelihood of the i-th subject is as follows:
L(yi; θ ) = log
(
1
T
T∑
t=1
p(yi|φ
(t)
i ; θ)
)
,
with φ
(t)
i ∼iid N (µ,Ω), for t = 1, . . . , T . By the strong law of large numbers, this esti-
mate L(y; θ) converges almost surely towards E[L(y; θ)]. However, this Monte-Carlo
estimate is susceptible to numerical instabilities and to computational precision is-
sues [31]. To avoid these numerical problems, we propose to estimate the likelihood
using an importance sampling procedure. The importance sampling estimates of the
log likelihood of the i-th subject is as follows:
L(yi; θ ) = log
(
1
T
T∑
t=1
p(yi|φ
(t)
i ; θ)p(φ
(t)
i ; θ)
hi(φ
(t)
i ; θ)
)
with hi(.; θ) any instrumental distribution and φ
(t)
i ∼iid hi(.; θ), for t = 1, . . . , T .
This estimate converges for the same reason as the regular Monte-Carlo estimate,
whatever the choice of the distribution hi. However, some choices of hi are obviously
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better than others, especially to reduce the variance of the estimate. Among the
distributions hi, it is possible to exhibit the optimal distribution that minimizes the
variance of the estimate [32]. For NLMEMs, this distribution is the individual pos-
terior distribution p(φ|yi; θ). However, because this distribution has no closed form
in NLMEMs, we propose for hi a Gaussian approximation of the i-th individual pos-
terior distribution (i.e. φ
(t)
i ∼ N (µ
post
i ,Ω
post
i )). For each i, the posterior individual
mean µposti and the posterior individual variance Ω
post
i are estimated by the empirical
mean and empirical variance of the φ
(m)
i simulated by the MCMC procedure.
3.4 Statistical tests
Let us assume that a scalar covariate effect β is tested on the k-th fixed effect. Let us
denote by Gi the value of the covariate for subject i. The vector Xi is Xi = (1, Gi)
and the fixed effect matrix is:
µ =
 µ1 . . . µk−1 µk µk+1 . . . µp
0 . . . 0 β 0 . . . 0

The null hypothesis to test is H0: {β = β0}, with the alternative hypothesis H1:
{β 6= β0}. Both the Wald test and the LRT can be performed to assess the covariate
effect. For the Wald test, the parameter βˆ and its variance V (β) = SE2(β) are
estimated with the SAEM algorithm under H1. The statistic SW = (βˆ − β0)
2/V (β)
follows a 1 degree of freedom χ21 distribution under H0. The rejection region of the
Wald test for a nominal level α is therefore {SW > χ
2
1;1−α}, where χ
2
1;1−α is the
critical value of the centered χ21 distribution. For the LRT, the maximum likelihood
estimates θ̂1 and θ̂0 of the models with and without the covariate effect respectively
are computed with SAEM. The log-likelihoods L1 = L(y; θ̂1) and L0 = L(y; θ̂0) of the
model with and without covariate effect respectively are estimated by importance
10
H
AL author m
anuscript    inserm
-00169790, version 1
sampling. The statistic SLRT = 2(L1 − L0) is computed. Under H0, SLRT follows
a χ21 distribution. The rejection region of the LRT test for a nominal level α is
therefore {SLRT > χ
2
1;1−α}. These 2 tests can easily be extended to a vector β
of covariate effects, the degrees of freedom for the χ2 distribution being then the
number of components of β.
3.5 Sample size computation
We propose a method to compute the power of a Wald test of a covariate effect
based on NLMEMs. This computation requires proceeding through the following
steps: specify the regression function and the NLMEM to be used; identify values
for the parameter θ; specify an experimental design (tij)1≤i≤N,1≤j≤ni ; identify the
covariate effect to test, (i.e. the alternative hypothesis H1); evaluate the standard
errors SEN , and finally, compute the power of the test. The minimum sample size
required for a given power is then deduced from these last 2 steps, which are detailed
below.
Let the tested parameter β be a scalar covariate effect on one fixed effect. For
a clinical trial aiming at detecting a covariate effect of at least (β1 − β0) on this
fixed effect, the alternative hypothesis of the test is H1: {β ≥ β1}. Under H1, the
statistic SW is asymptotically distributed with a non-centered χ
2
1 distribution with
a non-centrality parameter (β − β0)
2/V (β). Therefore, the power of the Wald test
is equal to:
p(β) =
∫ ∞
χ21;1−α
pi(x; 1, (β − β0)
2/V (β))dx (4)
where pi(x; 1, c) is the probability density function of the non-centered χ21 distri-
bution, with a non-centrality parameter c. To compute the expected variance or
standard error of β in an NLMEM, we propose to use the estimate of the Fisher
11
H
AL author m
anuscript    inserm
-00169790, version 1
information matrix provided by the SAEM algorithm and detailed in section 3.2.
When all patients have the same sampling design, a dataset with a covariate effect
β = β1 is generated with this sampling design and with a number Nsim of subjects
large enough to ensure a fine approximation of the expected SE by the observed
SE. The estimation of the Fisher information matrix is performed on this simulated
dataset using the SAEM algorithm. Because the Fisher information matrix of the
complete dataset is the sum of the individual Fisher information matrices, given the
hypothesis of an identical sampling design for each subject, the SE for a dataset of N
subjects, SEN(β), can be evaluated from the SE of the simulated dataset SENsim(β)
using SEN(β) = SENsim(β) ·
√
Nsim/N . Therefore, for a given design and a given
number of subjects N , the power of the Wald test can be evaluated from the equa-
tion (4). Finally, for a given power, the minimum sample size required is deduced
from this power evaluation.
4 Simulation study
4.1 Simulation settings
The objective of this simulation study is to illustrate some statistical properties of the
SAEM algorithm in the context of HIV viral dynamics. We evaluated the accuracy
of the parameter estimates, the SE and the likelihood estimates. We performed the
Wald test and the LRT in the context of group comparison tests, and lastly, we
computed the power of the Wald test.
The bi-exponential model for initial HIV dynamics proposed by Ding and Wu
[14] was used to simulate the datasets:
f(φi, tij) = log10(P1ie
−λ1itij + P2ie
−λ2itij).
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This function has p=4 individual parameters: P1i, P2i are the baseline values and
λ1i, λ2i 2-phase viral decay rates. These parameters are positive and distributed
according to a log-normal distribution. Thus, φi and µ take the following values:
φi = (lnP1i, lnP2i, lnλ1i, lnλ2i) and µ = (lnP1, lnP2, lnλ1, lnλ2). Identical sampling
times are assumed for all subjects. Additive Gaussian random effects are assumed
for each parameter with a diagonal covariance matrix Ω. Let ω2 = (ω21, ω
2
2, ω
2
3, ω
2
4)
denote the vector of the variances of the random effects. Additive Gaussian error
is assumed with a constant variance σ2 (i.e. g(φi, tj) = 1 for all i, j). For the fixed
effects, the values are those proposed by Ding and Wu [14]: lnP1 = 12, lnP2 = 8,
lnλ1 = ln(0.5), lnλ2 = ln(0.05). The inter-subject variability is identical for the 4
parameters: ω21 = ω
2
2 = ω
2
3 = ω
2
4 = 0.3 corresponding to a variation coefficient of
55%. The residual standard deviation is σ = 0.065, which corresponds to a variation
coefficient of 15% for the viral load. With the Matlab software, we generated N = 40
or N = 200 total number of subjects with n=6 blood samples per patient, taken on
days 1, 3, 7, 14, 28 and 56. A simulated dataset with N = 40 subjects is represented
on Figure 1.
0 10 20 30 40 50 60
0
1
2
3
4
5
6
Time (day)
lo
g 1
0 
vi
ra
l l
oa
d 
(cp
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L)
Figure 1: Simulated dataset with N = 40 subjects of the biexponential model
describing the HIV viral load decrease under treatment.
13
H
AL author m
anuscript    inserm
-00169790, version 1
4.2 Evaluation of estimates
Our aim is to evaluate the estimates produced by the SAEM algorithm. We fitted
the datasets with the simulation model and computed the relative bias and relative
root mean square error (RMSE) for each component of θ from 1000 replications
of the trial described below for N = 40 and N = 200 subjects, respectively. The
relative bias and RMSE on the 1000 data sets obtained for N = 40 and N = 200
subjects are presented in Table 1. For N = 40 subjects, the estimates have very
Table 1: Relative bias (%) and relative root mean square error (RMSE) (%) of the
estimated parameters evaluated by the SAEM algorithm from 1000 simulated trials
with N = 40 and N = 200 subjects.
Parameters Bias (%) RMSE (%)
N = 40 N = 200 N = 40 N = 200
ln P1 0.006 -0.003 0.78 0.35
ln P2 0.01 -0.003 1.23 0.55
ln λ1 0.48 -0.01 12.92 5.75
ln λ2 -0.04 0.01 3.03 1.36
ω21 -2.45 -0.38 25.59 10.88
ω22 -3.38 -1.21 29.02 12.19
ω23 -1.75 -0.17 22.94 10.60
ω24 -1.34 0.16 25.09 11.64
σ2 0.10 0.15 15.82 6.91
low bias (<1% for the fixed effects, <5% for the variance parameters). The RMSE
is satisfactory for the fixed effects (<13%) as well as for the variance parameters
(<30%). As expected with N = 200 subjects, both the bias and the RMSE decrease
with increasing subject number.
The SE estimated for each component of θ̂ by the SAEM algorithm are com-
pared with the “true” SE evaluated by the empirical standard deviation of the 1000
parameter estimates obtained for the simulated datasets. In Figure 2, for each com-
ponent of θ, the 1000 estimated SEs and the true SEs with N = 40 datasets are
plotted. For all parameters, the SEs estimated by SAEM are very close to the true
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Figure 2: Histograms of the 1000 relative SEs (%) estimated by SAEM for datasets
with N=40 subjects. The line represents an estimate of the “true” standard error
estimated on 1000 replications.
SEs. Similar results are observed with N = 200 datasets.
The influence of the size T of the random samples used to evaluate the likelihood
by importance sampling is studied for one dataset with N = 200 subjects. The log-
likelihood is evaluated successively for different sample sizes T = 1000 or 5000 or
10 000 or 50 000, with 10 replications for each T , using the Gaussian approximation
of the individual posterior distribution from the last 250 iterations of the SAEM
algorithm. Results are reported in Figure 3 and show that the variability of the
approximation is reduced by increasing the sample size. Therefore, the likelihood is
evaluated by the importance sampling procedure with a sample size T = 10 000, as
a balance between estimate accuracy and time consumption.
4.3 Evaluation of statistical tests
We performed a Wald test and an LRT to test the difference between two treatment
groups on the viral load decrease, especially on the first viral decay rate, lnλ1, as
proposed by Ding and Wu [14]. We considered that the two groups are of equal size
(i.e. 20 and 100 subjects per group when N = 40 and N = 200 subjects, respec-
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Figure 3: Log-likelihood estimates as a function of the sample size T used in the
importance sampling procedure with 10 replications for each T , for one dataset with
N = 200 subjects.
tively). The parameter vector θ is θ = (µ, ω2, σ2) under H0 and θ = (µ, β, ω
2, σ2)
under H1. We applied these tests using SAEM on the 1000 datasets simulated with
β = 0 and evaluated the type I error of both the Wald test and the LRT by the
proportion of trials for which H0 is rejected, because these datasets are simulated
without any treatment effect. We then evaluated the power of these tests for a
treatment effect of almost 30% between the 2 treatment groups on the parameter
lnλ1 (i.e. the alternative hypothesis H1: {β ≥ β1} with β1 = 0.262). The power is
estimated by the proportion of trials for which H0 is rejected, within 1000 datasets
simulated with a treatment effect β1 = 0.262 on lnλ1.
The estimation of the type I error for a nominal value of 5% and the powers
are given in Table 2 for datasets with 20 or 100 subjects per group. The estimated
Table 2: Evaluation on 1000 simulated datasets with 20 or 100 subjects per group
of the type I error and the power of the Wald test and LRT for a treatment effect
on the first decay rate.
Type I error Power
Number of subjects per group 20 100 20 100
Wald test 4.0% 4.5% 37.5 % 90.4%
LRT 5.8% 5.6% 38.2 % 85.4%
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type I errors are close to 5%, and given the dataset number of replications, do not
differ significantly from the expected 5% value. The estimated powers are similar
for the 2 tests and, as expected, are lower with N = 40 subjects than with N = 200
subjects.
4.4 Sample size computation example
The method proposed in section 3.5 to evaluate the power of the Wald test is applied
to the model, the parameter values and the sampling design detailed above, for
a difference of 30% between the 2 treatment groups in the parameter lnλ1 (i.e.
β1 = 0.262). A dataset is simulated with 2 groups of 5 000 subjects (i.e. N = 10 000
subjects), and with a treatment effect β1 on lnλ1. This dataset is analyzed using
the SAEM algorithm to evaluate the Fisher information matrix. A SE(βˆ) = 0.0112
is obtained for 5 000 subjects per group. Applying equation (4), a sample size of
20 subjects per group (N = 40) provides a power of 32%, and a sample size of 100
subjects per group (N = 200) provides a power of 92%. These 2 values are close
to the 2 estimated powers, obtained with the simulation study for the Wald test, of
37% and 90% respectively. Finally, the minimum sample size required to ensure a
power of at least 80% is 70 subjects per group (N = 140). These results illustrate
the ability of the SAEM approach to predict the SE of a fixed effect and the power
of the Wald test to compute the minimum sample size required for a given power.
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5 Effect of ritonavir on the indinavir pharmacoki-
netics in the COPHAR1-ANRS102 trial
5.1 Material and Methods
The COPHAR1-ANRS102 study was an open, multi-center, prospective trial includ-
ing HIV-infected adults given an antiretroviral combination of at least 3 drugs, one
being either indinavir or nelfinavir. Patients were required to have a baseline plasma
HIV RNA below 200 copies/mL and to have maintained the same antiretroviral
treatment for 6 months. Data on indinavir concentration were obtained for 45 pa-
tients who received different dosages of indinavir: 31 patients, indinavir alone three
times a day (for most, 800 mg), and 14 patients indinavir twice a day (for most, 800
mg) with a booster dose of 100mg of ritonavir. From each patient, 5 blood samples
were collected for the indinavir concentrations: a sample before indinavir adminis-
tration and samples at 0.5, 1, 3 and 6 hours after indinavir administration. More
details on this trial can be found in Goujard et al. [33]. The concentration data
of the indinavir group were analyzed with an NLMEM and the FOCE algorithm
implemented in the WinNonMix software by Brendel et al [34].
The aim of the present analysis is to evaluate the effect of the co-administration of
ritonavir on the pharmacokinetic parameters of indinavir using the SAEM algorithm
and the tests developed. The results are compared to those obtained with the
adaptative Gaussian quadrature (AGQ) method implemented in the SAS procedure
NLMIXED.
The pharmacokinetic statistical model proposed by Brendel et al [34] was used,
which is a one-compartment model with first-order absorption and first-order elim-
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Figure 4: Observed individual indinavir concentrations: (+) and (∆) for patients
receiving ritonavir or not respectively; predicted mean curves obtained with SAEM:
dotted line and plain line for patients receiving ritonavir or not respectively.
ination at steady-state:
f(φ, t) =
Dka
V ka − Cl
(
e−
Cl
V
t
(1− e−
Cl
V
τ )
−
e−kat
(1− e−kaτ )
)
where ka is the first-order absorption rate constant, Cl the oral clearance, V the oral
volume distribution and τ the delay between 2 drug administrations fixed to 12 and
8 h for patients receiving ritonavir or not, respectively. The individual parameters
are φ = (lnV, ln ka, lnCl). A diagonal variance matrix Ω and a homoscedastic error
model were used. The Wald test was used to test the effect of ritonavir administra-
tion on the fixed effects ka, Cl and V . The vector θ was estimated under H1 with
the SAEM algorithm and the procedure NLMIXED.
5.2 Results
Concentration data are displayed in Figure 4. The SAS procedure NLMIXED failed
to estimate the variability on ka which has to be fixed to 0. The SAEM algorithm
succeeded in the estimation of all the parameters and estimated the ka variability
to 10−7. Therefore, a model without a variability on ka was considered with both
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Table 3: Pharmacokinetic parameters of indinavir (estimate, SE (%) and p-value of
the Wald test) estimated with the SAEM and the adaptative Gaussian quadrature
(AGQ) algorithms
SAEM AGQ
Parameters Estimate SE (%) p-value Estimate SE (%) p-value
V (L) 46.70 32 43.80 22
ka (h−1) 0.76 22 0.78 14
Cl (L/h) 37.80 7 42.14 7
βV -0.59 89 0.154 -0.24 205 0.628
βka -0.90 32 0.002 -0.80 30 0.002
βCl -0.66 21 <.001 -0.62 22 <.001
ω2V 1.22 55 1.22 40
ω2Cl 0.05 50 0.07 51
σ2 2.40 12 2.77 12
estimation methods. The parameters estimated by the SAEM and the AGQmethods
for this model are presented in Table 3. To ensure convergence, 2000 iterations were
used for the SAEM algorithm and 30 nodes were used with the SAS procedure
NLMIXED. It takes about 90 s CPU time for the SAEM algorithm and 400 s CPU
time for the procedure NLMIXED to run on a conventional Intel Pentium IV 2.8
GHz workstation.
A significant effect of co-medication with ritonavir was found with the 2 methods
on ln ka and ln Cl (p < 0.01), resulting in a decrease of 0.41/h and 0.44/h of ka
with the SAEM and the AGQ method, respectively, and a decrease of 0.51 L/h and
0.53 L/h of Cl with the SAEM and the AGQ method, respectively, when patients
received ritonavir. The effect of ritonavir on V is not significant with both methods.
The log-likelihood evaluated by the importance sampling procedure was equal to
-469.6 at the estimates obtained with SAEM and equal to -472.1 at the estimates
obtained with the AGQ method. The predicted concentrations of indinavir with
and without ritonavir evaluated at the fixed effect values obtained with SAEM are
overlayed on the plot of concentrations data of Figure 4. This graph illustrates the
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slower decrease in indinavir concentration when it is co-administered with ritonavir.
6 Discussion
In this paper, we propose statistical tests for covariate effects in NLMEMs adapted
to non-linear longitudinal data analysis. Because these tests take into account all the
data, they are obviously more powerful than tests using only the final measurements.
In the context of NLMEMs, several tests taking into account all the data have been
proposed. However, those based on approximate methods have poor properties,
especially with increase of the type I error. More recently, tests from numerical inte-
gration based methods, such as the adaptative Gaussian quadratures have also been
proposed, even though they can be limited by slow convergence when the number of
parameters is large. We propose here statistical tests based on the SAEM algorithm,
which has good computational properties. The SAEM algorithm and the statistical
tests proposed in this paper are implemented in a Matlab function called MONO-
LIX and freely available on http://mahery.math.u-psud.fr/∼lavielle/monolix. The
simulation study illustrates the accuracy of the SAEM algorithm to fit non-linear
longitudinal data in the context of HIV viral load decrease, the parameter estimates
being unbiased and with small RMSE. The SEs of the parameters are evaluated
from the Fisher information matrix. We propose an estimation of this matrix with
the stochastic approximation procedure of the SAEM algorithm and Louis’ prin-
ciple [29]. Results of the simulation study show that the SE estimates are very
close to the “true” SEs evaluated on 1000 simulated datasets. Kuhn and Lavielle
[27] propose to estimate the likelihood with a simple Monte Carlo procedure, but
this method provides poor estimates and is prone to computational instabilities. To
avoid this problem, we propose an importance sampling approach, with a Gaussian
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approximation of the conditional posterior distribution used to sample the individ-
ual parameter. Hence, the Wald test and the LRT based on these Fisher information
matrix and likelihood estimation procedures have accurate properties, especially the
obtained type I errors are close to the expected threshold of 5%.
Another critical issue for NLMEMs is the computation of the minimum sample
size required to observe a significant covariate effect on a fixed effect parameter with
the Wald test. This issue requires evaluation of the expected SE for this covariate
effect. Kang et al. [30] propose an analytic evaluation based on the linearization
of the model, a method to be compared with the extension of the PFIM function
for covariates proposed by Retout et al. [35]. However Kang et al. [30] show
that this method underestimates the power of the test when the random effect
variability increases. An alternative to this linearization method is to compute
the expected Fisher information matrix with the SAEM estimate. A large dataset
is simulated to be close to asymptotic results, from which the Fisher information
matrix is estimated using SAEM. We show on the HIV example that the power
predicted by this method is close to that evaluated on the simulation study. In this
example, the same elementary design is used in every patient. This can easily be
extended when the population design is composed of different groups of elementary
designs [30].
Finally, the SAEM algorithm and the proposed tests are used to analyze the
indinavir pharmacokinetics and to test the effect of the co-administration of ritonavir
in HIV infected patients from the COPHAR 1-ANRS102 trial. As expected, a
significant effect of ritonavir co-administration is found on the absorption and the
elimination of indinavir [34]. Similar results were obtained with the two methods on
this model. However models with more random effects may be difficult to analyse
with the AGQ method.
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The SAEM algorithm provides accurate estimates when working with NLMEMs
and may be applied to even more difficult issues. For instance, when measuring a
biological response such as a concentration or a viral load, the observations may be
left-censored, due to the limits of quantification of the measuring equipment. We
extended the SAEM algorithm to this case, the left-censored data being considered
as non-observed data as well as the random effects [36].
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